{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Infection",
      "comorbidities",
      "covid-19",
      "management",
      "psoriasis",
      "risk"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34696673",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "11",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "11",
        "Day": "01"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1080/1744666X.2021.1997592"
    ],
    "Journal": {
      "ISSN": "1744-8409",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "11",
        "PubDate": {
          "Year": "2021",
          "Month": "Nov"
        }
      },
      "Title": "Expert review of clinical immunology",
      "ISOAbbreviation": "Expert Rev Clin Immunol"
    },
    "ArticleTitle": "Risk of infections in psoriasis: assessment and challenges in daily management.",
    "Pagination": {
      "StartPage": "1211",
      "EndPage": "1220",
      "MedlinePgn": "1211-1220"
    },
    "Abstract": {
      "AbstractText": [
        "In daily practice management of psoriasis, evaluation of risk factors for infections is having a growing influence. Indeed, in psoriatic patients, risk of infections may be due to psoriasis itself, immunomodulatory therapy, and comorbidities that may increase this risk and patient hospitalization.",
        "Given the greater understanding of psoriasis pathogenesis and the increasing number of treatment options, it is particularly important to customize therapy according to each, single patient; psoriasis features and comorbidities are also essential to tailor treatment goals.",
        "In this perspective, the current knowledge on the infectious risk in psoriatic patient, related to comorbidities, such as diabetes mellitus, cardiovascular disease, and chronic obstructive pulmonary, to 'special populations,' to chronic infections, such as latent tuberculosis, chronic hepatitis B and C, and HIV, and to the most recent Covid-19 pandemic scenario, is reviewed and discussed in order to suggest the most appropriate approach and achieve the best available therapeutic option."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Dermatology, Catholic University, Rome, Italy."
          },
          {
            "Identifier": [],
            "Affiliation": "Dermatology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy."
          }
        ],
        "LastName": "De Simone",
        "ForeName": "Clara",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy."
          }
        ],
        "LastName": "Fargnoli",
        "ForeName": "Maria Concetta",
        "Initials": "MC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine and Aging Science and Dermatologic Clinic, University \"G. d'Annunzio\", Chieti-Pescara, Italy."
          }
        ],
        "LastName": "Amerio",
        "ForeName": "Paolo",
        "Initials": "P"
      },
      {
        "Identifier": [
          "0000-0001-8697-6896"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dermatology Unit, Department of Systems Medicine, Tor Vergata University of Rome, Italy."
          }
        ],
        "LastName": "Bianchi",
        "ForeName": "Luca",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy."
          }
        ],
        "LastName": "Esposito",
        "ForeName": "Maria",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Dermatology, Catholic University, Rome, Italy."
          },
          {
            "Identifier": [],
            "Affiliation": "Dermatology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy."
          }
        ],
        "LastName": "Pirro",
        "ForeName": "Federico",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dermatology Unit \"Daniele Innocenzi\", Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy."
          }
        ],
        "LastName": "Potenza",
        "ForeName": "Concetta",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit of Dermatology, Department of Health Science, University of Florence, Florence, Italy."
          }
        ],
        "LastName": "Ricceri",
        "ForeName": "Federica",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, via Universit\u00e0 40, 09124 Cagliari, Italy, IRCCS San Raffaele Hospital, Vita Salute University, Milan, Italy."
          }
        ],
        "LastName": "Rongioletti",
        "ForeName": "Franco",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Section of Dermatology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy."
          }
        ],
        "LastName": "Stingeni",
        "ForeName": "Luca",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unit of Dermatology, Department of Health Science, University of Florence, Florence, Italy."
          }
        ],
        "LastName": "Prignano",
        "ForeName": "Francesca",
        "Initials": "F"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Expert Rev Clin Immunol",
    "NlmUniqueID": "101271248",
    "ISSNLinking": "1744-666X"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Cardiovascular Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Comorbidity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "epidemiology",
        "therapy"
      ],
      "DescriptorName": "Psoriasis"
    },
    {
      "QualifierName": [
        "methods",
        "statistics & numerical data"
      ],
      "DescriptorName": "Risk Assessment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Virus Diseases"
    }
  ]
}